about
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review.Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts.Platelet Derived Growth Factor BB: A "Must-have" Therapeutic Target "Redivivus" in Ovarian Cancer.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis.Epigenetic control of the tumor microenvironment.The Heterocellular Emergence of Colorectal CancerMicroRNAs in gynecological cancers: Small molecules with big implications.Metabolism shapes the tumor microenvironment.Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer.TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells.Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer.Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancerChemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancerOvarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
P2860
Q30244418-BC265A49-225C-4402-93EA-41806F6FB66BQ33747629-11A5668A-FC5B-405B-AD38-018535CFFCACQ37570010-4EDA3EA6-F4DC-4213-913F-81E09B195A64Q37620476-3CB74264-B9A8-4B7A-BEE3-4130DD9913B1Q37661852-590F6321-5394-422D-9E61-F07591404578Q38971785-38632DE7-D932-4755-AD6C-6739A1C0FEF5Q39152114-3B93CD2A-5949-484C-B8AE-C1C75269A6E5Q39333266-0A3C05E8-EBBB-49C3-B3FF-130D1C3F9BBEQ39367096-27299D6F-93D6-4AD6-844B-873B846642C3Q41660578-6768849C-DE04-461F-94B0-138772F26CF4Q47133116-7C3EF4E2-6D3F-485A-B66C-1652BE75946CQ47679295-88CA00F6-96E9-4FE0-A001-A29EB84EE705Q47685928-E5465CB2-EFF2-4F87-8EE1-F42AF4E15C2DQ49508672-473863E6-C586-4D0C-9517-792705290B36Q49885235-BF981629-979E-4092-A38B-CF6BE8590B8AQ57817294-8D80A45B-DADE-4B0F-A95E-748649A27836Q58703256-EE69FCA1-0EDD-40E2-85B6-FD0884AF36DDQ59126829-1CEB4362-3A0B-4627-9B6B-97A96F202E7E
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the tumour microenvironment in ovarian cancer
@ast
Targeting the tumour microenvironment in ovarian cancer
@en
type
label
Targeting the tumour microenvironment in ovarian cancer
@ast
Targeting the tumour microenvironment in ovarian cancer
@en
prefLabel
Targeting the tumour microenvironment in ovarian cancer
@ast
Targeting the tumour microenvironment in ovarian cancer
@en
P2093
P2860
P1476
Targeting the tumour microenvironment in ovarian cancer
@en
P2093
Anil K Sood
Jean M Hansen
Robert L Coleman
P2860
P304
P356
10.1016/J.EJCA.2015.12.016
P577
2016-02-02T00:00:00Z